Cargando…

Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection

The coronavirus disease 2019 (COVID-19) pandemic is an exceptional public health crisis that demands the timely creation of new therapeutics and viral detection. Owing to their high specificity and reliability, monoclonal antibodies (mAbs) have emerged as powerful tools to treat and detect numerous...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hwang, Yu-Chyi, Lu, Ruei-Min, Su, Shih-Chieh, Chiang, Pao-Yin, Ko, Shih-Han, Ke, Feng-Yi, Liang, Kang-Hao, Hsieh, Tzung-Yang, Wu, Han-Chung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724751/ https://www.ncbi.nlm.nih.gov/pubmed/34983527 http://dx.doi.org/10.1186/s12929-021-00784-w

Ejemplares similares

Monoclonal Antibodies against Nucleocapsid Protein of SARS-CoV-2 Variants for Detection of COVID-19
por: Lu, Ruei-Min, et al.
Publicado: (2021)

Monoclonal antibodies against S2 subunit of spike protein exhibit broad reactivity toward SARS-CoV-2 variants
por: Ko, Shih-Han, et al.
Publicado: (2022)

Antibody cocktail effective against variants of SARS-CoV-2
por: Liang, Kang-Hao, et al.
Publicado: (2021)

Neutralization or enhancement of SARS-CoV-2 infection by a monoclonal antibody targeting a specific epitope in the spike receptor-binding domain
por: Lai, Guan-Chun, et al.
Publicado: (2022)

Novel monoclonal antibody against integrin α3 shows therapeutic potential for ovarian cancer
por: Ke, Feng‐Yi, et al.
Publicado: (2020)

Broadly neutralizing human antibodies against Omicron subvariants of SARS-CoV-2
por: Chiang, Hsiao-Ling, et al.
Publicado: (2023)

A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies
por: Kumari, Monika, et al.
Publicado: (2022)

Neutralizing Monoclonal Antibodies Inhibit SARS-CoV-2 Infection through Blocking Membrane Fusion
por: Li, Chia-Jung, et al.
Publicado: (2022)

Monoclonal antibody targeting the conserved region of the SARS-CoV-2 spike protein to overcome viral variants
por: Wu, Wan-Ling, et al.
Publicado: (2022)

An efficient approach for SARS-CoV-2 monoclonal antibody production via modified mRNA-LNP immunization
por: Hsu, Fu-Fei, et al.
Publicado: (2022)

Development of mouse monoclonal antibody for detecting hemagglutinin of avian influenza A(H7N9) virus and preventing virus infection
por: Chiang, Yi-Wei, et al.
Publicado: (2021)

Development of therapeutic antibodies for the treatment of diseases
por: Lu, Ruei-Min, et al.
Publicado: (2020)

Broadly neutralizing antibodies against Omicron variants of SARS-CoV-2 derived from mRNA-lipid nanoparticle-immunized mice
por: Lu, Ruei-Min, et al.
Publicado: (2023)

SARS-CoV-2 spike S2-specific neutralizing antibodies
por: Li, Chia-Jung, et al.
Publicado: (2023)

Bivalent mRNA vaccine effectiveness against SARS-CoV-2 variants of concern
por: Kumari, Monika, et al.
Publicado: (2023)

CGRP-monoclonal antibodies and SARS-CoV-2 vaccination
por: Schiano di Cola, Francesca, et al.
Publicado: (2022)

Functionality of Monoclonal Antibody Therapy in SARS-CoV-2
por: Ali, Ruhma, et al.
Publicado: (2022)

Monoclonal antibody therapies against SARS-CoV-2
por: Focosi, Daniele, et al.
Publicado: (2022)

Long-term passaging of pseudo-typed SARS-CoV-2 reveals the breadth of monoclonal and bispecific antibody cocktails
por: Ma, Hang, et al.
Publicado: (2023)

Structure-guided antibody cocktail for prevention and treatment of COVID-19
por: Su, Shih-Chieh, et al.
Publicado: (2021)

Expression and membrane integration of SARS-CoV M protein
por: Ma, Hsin-Chieh, et al.
Publicado: (2008)

Novel Monoclonal Antibodies and Recombined Antibodies Against Variant SARS-CoV-2
por: Xie, Jiajia, et al.
Publicado: (2021)

Effect of monoclonal antibody therapy on the endogenous SARS-CoV-2 antibody response
por: Kim, Paul S., et al.
Publicado: (2022)

Development of SARS-CoV-2 Nucleocapsid Specific Monoclonal Antibodies
por: Terry, James S., et al.
Publicado: (2020)

Production and Characterization of Monoclonal Antibodies Against the Nucleocapsid Protein of SARS-COV
por: Fang, Ying, et al.
Publicado: (2006)

Development of Monoclonal Antibodies to Detect for SARS-CoV-2 Proteins
por: Mishra, Nawneet, et al.
Publicado: (2022)

SARS-CoV-2 Monoclonal Antibodies in Children: Ethical Considerations
por: Wolfe, Ian D., et al.
Publicado: (2021)

Collection of Monoclonal Antibodies Targeting SARS-CoV-2 Proteins
por: Pribanić Matešić, Marina, et al.
Publicado: (2022)

Monoclonal antibodies binding data for SARS-CoV-2 proteins
por: Mishra, Nawneet, et al.
Publicado: (2022)

Neutralisation of SARS-CoV-2 by monoclonal antibody through dual targeting powder formulation
por: Seow, Han Cong, et al.
Publicado: (2023)

Development and characterization of mouse monoclonal antibodies targeting to distinct epitopes of Zika virus envelope protein for specific detection of Zika virus
por: Li, Chia-Jung, et al.
Publicado: (2021)

In vivo biodistribution and pharmacokinetics of sotrovimab, a SARS-CoV-2 monoclonal antibody, in healthy cynomolgus monkeys
por: Aweda, Tolulope A., et al.
Publicado: (2022)

A monoclonal antibody that neutralizes SARS-CoV-2 variants, SARS-CoV, and other sarbecoviruses
por: Wang, Pengfei, et al.
Publicado: (2021)

A monoclonal antibody that neutralizes SARS-CoV-2 variants, SARS-CoV, and other sarbecoviruses
por: Wang, Pengfei, et al.
Publicado: (2021)

A human monoclonal antibody blocking SARS-CoV-2 infection
por: Wang, Chunyan, et al.
Publicado: (2020)

Potent mouse monoclonal antibodies that block SARS-CoV-2 infection
por: Guo, Youjia, et al.
Publicado: (2021)

Development of a SARS-CoV-2 nucleocapsid specific monoclonal antibody
por: Terry, James S., et al.
Publicado: (2021)

Anti-SARS-CoV-2 neutralizing monoclonal antibodies: clinical pipeline
por: Tuccori, Marco, et al.
Publicado: (2020)

Development and characterization of SARS-CoV-2 variant-neutralizing monoclonal antibodies
por: Qiu, Hongyu, et al.
Publicado: (2021)

Current status of therapeutic monoclonal antibodies against SARS-CoV-2
por: Kumar, Sanjeev, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cp21q18f7b2t932ct9nfijnf3p